EEC Budget at Impasse

LONDON—"Agriculture has a lobby. Research and development does not." That comment last month from Karl-Heinz Narjes, vice president of the European Economic Community, summarized the problems facing the 12 nations in the Community as they struggled to agree on a new budget for collaborative research during the next five years. West Germany, France and Britain, joined in December by the Netherlands, have been calling for a major reduction in the European Commission's ambitious proposal for

Written byBernard Dixon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

That comment last month from Karl-Heinz Narjes, vice president of the European Economic Community, summarized the problems facing the 12 nations in the Community as they struggled to agree on a new budget for collaborative research during the next five years.

West Germany, France and Britain, joined in December by the Netherlands, have been calling for a major reduction in the European Commission's ambitious proposal for a budget of $7.95 billion for the period 1987-1991. They argue that the amount is unrealistically high in light of the overall financial crisis caused by the Community's agricultural policy. Smaller EEC partners have supported the plan, which they see as a way to benefit from collaborative projects that would be too costly and complex for them to pursue alone.

These budget squabbles have made increasingly uncertain the future of three major projects: Esprit, a program of information technology research linking universities and industry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies